It was with some disappointment but mostly a sense of achievement that I recently finished my 8-year tenure as the Medical Director of Australia’s first Medically Supervised Injecting Centre (MSIC).

I was appointed to this position in February 2000 on a half-time basis while also continuing on as the Director of the Kirketon Road Centre – a primary health care facility of the South Eastern Sydney and Illawarra Area Health Service located in Kings Cross, which I had directed since 1989 and now return to full time.

I am proud of the MSIC’s achievements – the staff have successfully treated 2,458 drug overdoses onsite in the past 7 years, while ambulance callouts to heroin overdoses in the area decreased by 80%, thereby freeing these up to attend other medical emergencies.

The MSIC continues to enjoy broad-based support from the local community; notably 68% of local business managers and 80% of local residents who were resident in the area before the MSIC supported its establishment when last surveyed. The Kings Cross Business Partnership (which replaced the Chamber of Commerce post-bankruptcy) has credited the MSIC for helping business recovery in Kings Cross for having reduced street-based drug injecting.

The jury is well and truly in as far as the international research community is concerned so far as the merits of supervised injecting facilities. They are now well recognised as effective in reducing drug-related harm associated with street-based injecting to both individual drug user and greater community. The Sydney centre is considered to be exemplary of the 76 or so such facilities operating in 8 different countries today.

So why I am disappointed? The reason is that the MSIC continues to operate on a trial basis, rather than as the accepted and much-needed legitimate health care facility that it is. The most recent 4-year extension to the trial - making it a record-breaking 10 and a half year scientific trial with little end in sight - was passed by the NSW Government in June last year.

It’s now time the NSW Government revisited the trial status of the MSIC. I whole-heartedly support the ongoing rigorous evaluation and monitoring of health services to ensure their effectiveness, particularly in the illicit drugs area as needs can change over time, but the MSIC’s apparently endless trial status is a barrier to its integration with the rest of the public health system. This affects continuity of care, workforce development and staff morale, especially as the end of each trial period draws near.

It’s time the trial was declared a success, and we moved on. What might help the NSW Government to move in this direction?